Price T Rowe Associates Inc APELLIS PHARMACEUTICALS INC Transaction History

Price T Rowe Associates Inc

  • $816 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
N/A
-355,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
N/A
20,000 Added 5.97%
355,000 $538,000
Q3 2021

Nov 15, 2021
SELL
N/A
-115,000 Reduced 25.56%
335,000 $414,000
Q2 2021

Aug 16, 2021
BUY
N/A
450,000 New
450,000 $840,000
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email